LTF and early-onset autosomal dominant Alzheimer disease: Given the wide range of effects (antioxidant, anti-inflammatory, renin-angiotensin-system inhibitory, antibacterial, antiviral, antifungal) of lactoferrin, lysozyme, and ovotransferrin proteins in the supplement and evidence for the benefit of these proteins in various disease models (e.g., hypertension [65], inflammatory bowel disease [30,66], peritonitis [36], Alzheimer's disease [67]), coupled with the good adherence and safety of the study supplement, there is justification to investigate the therapeutic potential in other disease conditions as well.